1. Home
  2. LNAI vs IINN Comparison

LNAI vs IINN Comparison

Compare LNAI & IINN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LNAI
  • IINN
  • Stock Information
  • Founded
  • LNAI N/A
  • IINN 2018
  • Country
  • LNAI United States
  • IINN Israel
  • Employees
  • LNAI N/A
  • IINN 37
  • Industry
  • LNAI Biotechnology: Pharmaceutical Preparations
  • IINN Medical/Dental Instruments
  • Sector
  • LNAI Health Care
  • IINN Health Care
  • Exchange
  • LNAI Nasdaq
  • IINN Nasdaq
  • Market Cap
  • LNAI 29.9M
  • IINN 32.4M
  • IPO Year
  • LNAI N/A
  • IINN 2021
  • Fundamental
  • Price
  • LNAI $0.96
  • IINN $1.00
  • Analyst Decision
  • LNAI
  • IINN Strong Buy
  • Analyst Count
  • LNAI 0
  • IINN 1
  • Target Price
  • LNAI N/A
  • IINN $2.00
  • AVG Volume (30 Days)
  • LNAI 209.6K
  • IINN 250.3K
  • Earning Date
  • LNAI 11-13-2025
  • IINN 10-01-2025
  • Dividend Yield
  • LNAI N/A
  • IINN N/A
  • EPS Growth
  • LNAI N/A
  • IINN N/A
  • EPS
  • LNAI N/A
  • IINN N/A
  • Revenue
  • LNAI N/A
  • IINN $289,000.00
  • Revenue This Year
  • LNAI N/A
  • IINN N/A
  • Revenue Next Year
  • LNAI N/A
  • IINN $2,582.74
  • P/E Ratio
  • LNAI N/A
  • IINN N/A
  • Revenue Growth
  • LNAI N/A
  • IINN N/A
  • 52 Week Low
  • LNAI $0.90
  • IINN $0.40
  • 52 Week High
  • LNAI $21.00
  • IINN $1.65
  • Technical
  • Relative Strength Index (RSI)
  • LNAI N/A
  • IINN 34.12
  • Support Level
  • LNAI N/A
  • IINN $1.01
  • Resistance Level
  • LNAI N/A
  • IINN $1.13
  • Average True Range (ATR)
  • LNAI 0.00
  • IINN 0.06
  • MACD
  • LNAI 0.00
  • IINN -0.01
  • Stochastic Oscillator
  • LNAI 0.00
  • IINN 6.01

About IINN Inspira Technologies Oxy B.H.N. Ltd.

Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Share on Social Networks: